# News Psychedelics Category Implementation Log

## Overview
Added "Psychedelics" as a new category to the News section with dedicated stock ticker featuring 7 leading psychedelic medicine companies.

## Changes Made

### 1. Frontend - News Category Tab
**Modified**: `/app/frontend/src/pages/NewsPage.js`

**Change:**
- Added "Psychedelics" tab to category tabs
- Updated grid from `grid-cols-7` to `grid-cols-8`
- Positioned between "Cannabis" and "Crypto" categories

**New Tab Order:**
1. All
2. Cannabis
3. **Psychedelics** (NEW)
4. Crypto
5. AI
6. Market
7. International
8. Jamaica

### 2. Backend - Stock Ticker
**Modified**: `/app/backend/server.py`

**Endpoint**: `GET /api/ticker?category=psychedelics`

**Added 7 Psychedelic Stocks:**

---

## Psychedelic Stocks Added

### 1. **COMPASS Pathways (CMPS)** üíé
- **Price**: $7.82
- **Sector**: Clinical-stage biopharmaceutical
- **Focus**: COMP360 psilocybin therapy for treatment-resistant depression
- **Status**: NASDAQ-listed, Phase 3 trials
- **Headquarters**: London, UK

### 2. **Mind Medicine (MNMD)** üß†
- **Price**: $5.45
- **Sector**: Psychedelic drug development
- **Focus**: LSD, MDMA, and DMT therapies
- **Status**: NASDAQ-listed, multiple clinical trials
- **Headquarters**: New York, USA

### 3. **ATAI Life Sciences (ATAI)** üî¨
- **Price**: $1.23
- **Sector**: Biopharmaceutical platform
- **Focus**: Multiple psychedelic compounds portfolio
- **Status**: NASDAQ-listed, backed by Peter Thiel
- **Headquarters**: Berlin, Germany

### 4. **Cybin Inc (CYBN)** üåø
- **Price**: $0.89
- **Sector**: Psychedelic therapeutics
- **Focus**: Psilocybin and DMT derivatives
- **Status**: NYSE American-listed
- **Headquarters**: Toronto, Canada

### 5. **Numinus Wellness (NUMI)** üè•
- **Price**: $0.34
- **Sector**: Mental health care & research
- **Focus**: Psychedelic-assisted therapy clinics
- **Status**: TSX-V listed, licensed producer
- **Headquarters**: Vancouver, Canada

### 6. **Field Trip Health (FTRP)** üåà
- **Price**: $0.18
- **Sector**: Psychedelic therapy clinics
- **Focus**: Ketamine and psychedelic clinics
- **Status**: Canadian & US operations
- **Headquarters**: Toronto, Canada

### 7. **Red Light Holland (TRIP)** üçÑ
- **Price**: $0.06
- **Sector**: Psilocybin truffles & education
- **Focus**: Legal psychedelic products
- **Status**: CSE-listed, operating in Netherlands
- **Headquarters**: Toronto, Canada

---

## Ticker Behavior

### Price Volatility:
**Higher than cannabis stocks to reflect market reality:**
- CMPS, MNMD: ¬±6-7% daily swings
- ATAI: ¬±8% volatility
- CYBN: ¬±9% movements
- NUMI: ¬±10% fluctuations
- FTRP: ¬±12% high volatility
- TRIP: ¬±15% extreme volatility (penny stock)

### Update Frequency:
- Ticker refreshes every 10 seconds
- Live animation on news page
- Random price fluctuations within realistic ranges

### Display Format:
```
CMPS $7.82 +3.45%
MNMD $5.45 -2.18%
ATAI $1.23 +5.67%
...
```

## News Filtering

### How It Works:

**When "Psychedelics" tab is clicked:**
1. Frontend sends request to `/api/news?category=psychedelics`
2. Backend filters news articles tagged with "psychedelics" category
3. Ticker updates to show 7 psychedelic stocks
4. Live updates every 10 seconds

**News Categories Supported:**
- Company earnings reports
- Clinical trial results
- FDA announcements
- Regulatory changes
- Merger & acquisition news
- Research breakthroughs
- Market analysis

## Stock Information

### Market Characteristics:

**Sector**: Emerging psychedelic medicine industry

**Key Themes:**
- Clinical trials for mental health
- FDA Breakthrough Therapy designations
- Legalization & decriminalization efforts
- Institutional investment growth
- Patent development

**Investment Thesis:**
- $10B+ addressable market
- Treatment-resistant depression (TRD) focus
- PTSD and addiction treatments
- Growing clinical evidence
- Regulatory momentum

### Company Highlights:

**COMPASS Pathways (CMPS):**
- Leading psilocybin therapy company
- Phase 3 trial for TRD (largest ever)
- 25mg COMP360 synthetic psilocybin
- Partnership with NHS, European sites
- $100M+ funding raised

**Mind Medicine (MNMD):**
- Project Lucy (LSD for anxiety)
- Project Flow (MDMA for ADHD)
- 18-MC for addiction
- Multiple Phase 2 trials
- Nasdaq uplist success

**ATAI Life Sciences (ATAI):**
- Portfolio of 10+ companies
- Psilocybin, DMT, ibogaine programs
- Peter Thiel-backed
- $362M IPO in 2021
- Ecosystem approach

**Cybin Inc (CYBN):**
- CYB003 deuterated psilocybin
- CYB004 deuterated DMT
- Faster-acting formulations
- Phase 2 trials ongoing
- Innovation focus

**Numinus Wellness (NUMI):**
- Licensed psilocybin producer (Canada)
- Operating psychedelic therapy clinics
- Research partnerships
- Therapist training programs
- Integrated care model

**Field Trip Health (FTRP):**
- 10+ ketamine clinics in US/Canada
- FT-104 psychedelic molecule
- At-home ketamine therapy
- Integration coaching
- Retail footprint

**Red Light Holland (TRIP):**
- Psilocybin truffle products (legal in NL)
- iMicrodose packs
- Education & brand building
- Music festival partnerships
- Consumer products focus

## Technical Implementation

### Frontend Changes:
```javascript
// Added to category tabs
<TabsTrigger value="psychedelics">Psychedelics</TabsTrigger>

// Grid updated from 7 to 8 columns
<TabsList className="grid grid-cols-8">
```

### Backend Changes:
```python
# New ticker category
if category == 'psychedelics':
    psychedelic_stocks = [
        {'symbol': 'CMPS', 'price': 7.82, 'change': random...},
        # ... 7 stocks total
    ]
    ticker_data.extend(psychedelic_stocks)
```

### API Response:
```json
{
  "ticker": [
    {
      "symbol": "CMPS",
      "name": "COMPASS Pathways",
      "price": 7.82,
      "change": 3.45,
      "type": "psychedelics"
    }
  ]
}
```

## Visual Display

### Ticker Bar:
- Red "LIVE" indicator with pulse animation
- Horizontal scrolling ticker
- Company symbols in white
- Prices in gray
- Changes in green (positive) or red (negative)
- Percentage change with +/- prefix

### Tab Styling:
- Consistent with other category tabs
- Slate-800 background
- White text when active
- Hover effects
- Responsive grid layout

## News Article Integration

### Expected News Sources:
- **Medical**: Clinical trial results, FDA updates
- **Business**: Earnings, funding rounds, partnerships
- **Research**: Scientific publications, conference presentations
- **Regulatory**: Decriminalization news, policy changes
- **Market**: Stock analysis, sector reports
- **Industry**: Company announcements, product launches

### Article Metadata:
- Title, description, link
- Published timestamp
- Source (e.g., "Psychedelic Spotlight", "MAPS", "FDA")
- Category tag: "psychedelics"
- Sentiment: bullish/bearish/neutral

## Future Enhancements

### Stock Features:
1. **Real-time Prices**: Integration with financial APIs
2. **Price Charts**: 7-day/30-day historical data
3. **Market Cap**: Display company valuations
4. **52-Week Range**: High/low prices
5. **Volume**: Trading volume indicators
6. **News Correlation**: Link stock movement to news

### News Features:
1. **Clinical Trial Tracker**: Phase updates for each company
2. **FDA Calendar**: Upcoming decision dates
3. **Conference Coverage**: Live updates from psychedelic conferences
4. **Research Library**: Academic papers and studies
5. **Company Profiles**: Detailed pages for each stock
6. **Analyst Ratings**: Buy/hold/sell recommendations

### Educational Content:
1. **Sector Overview**: Introduction to psychedelic medicine
2. **Investment Guide**: How to invest in the sector
3. **Risk Disclosure**: Volatility warnings
4. **Clinical Glossary**: Terms like Phase 2, TRD, etc.
5. **Regulatory Timeline**: Legalization tracking by jurisdiction

## Market Context

### Industry Growth:
- **2021**: $2B market size
- **2025**: $5B estimated
- **2030**: $10B+ projected
- **CAGR**: 16-18% growth rate

### Key Catalysts:
- Phase 3 trial results (COMPASS COMP360)
- FDA approvals (expected 2025-2027)
- State-level legalization (Oregon, Colorado)
- Insurance coverage decisions
- Major pharma partnerships

### Investment Risks:
- Clinical trial failures
- Regulatory delays
- Dilution through offerings
- Market volatility
- Early-stage companies
- Lack of revenue (most companies)

## SEO & Discovery

### Keywords:
- Psychedelic stocks
- Psilocybin companies
- COMPASS Pathways news
- Mind Medicine stock
- Psychedelic medicine investing
- CMPS MNMD ATAI stock price
- Ketamine therapy companies

### Meta Description:
"Track psychedelic medicine stocks including COMPASS Pathways (CMPS), Mind Medicine (MNMD), and ATAI Life Sciences. Latest news, clinical trial updates, and market analysis."

## Compliance & Disclaimers

### Investment Disclaimer:
"Stock prices are for informational purposes only. Not financial advice. Psychedelic medicine is an emerging, high-risk sector. Clinical trials may fail. Consult financial advisor before investing."

### Medical Disclaimer:
"Information about psychedelic therapies is educational only. These treatments are experimental and not FDA-approved for general use. Consult healthcare provider for medical advice."

### Legal Status:
"Psilocybin and related compounds remain Schedule I controlled substances in most jurisdictions. Legal status varies by location. Some companies operate under research exemptions or in jurisdictions with decriminalization."

## Testing Checklist

- ‚úÖ Psychedelics tab appears in news section
- ‚úÖ Tab positioned correctly (after Cannabis, before Crypto)
- ‚úÖ Clicking tab filters to psychedelics category
- ‚úÖ Ticker displays 7 psychedelic stocks
- ‚úÖ Stock prices update every 10 seconds
- ‚úÖ Percentage changes show red/green colors
- ‚úÖ Ticker animation scrolls smoothly
- ‚úÖ Responsive on mobile/tablet/desktop
- ‚úÖ Backend API returns correct data
- ‚úÖ No errors in browser console

## Files Modified

### Frontend:
- `/app/frontend/src/pages/NewsPage.js` - Added psychedelics category tab

### Backend:
- `/app/backend/server.py` - Added psychedelics ticker endpoint

### Documentation:
- `/app/NEWS_PSYCHEDELICS_CATEGORY_LOG.md` - This file

---

**Status**: ‚úÖ Complete - Psychedelics category is live in News section!

**Category Tab**: Cannabis ‚Üí **Psychedelics** ‚Üí Crypto

**Ticker Stocks**: 7 companies (CMPS, MNMD, ATAI, CYBN, NUMI, FTRP, TRIP)

**API Endpoint**: `GET /api/ticker?category=psychedelics`

**Price Range**: $0.06 - $7.82

**Updated**: October 15, 2025
